SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sigachi Industries’ arm achieves certificate of suitability for ‘Metformin Hydrochloride’

07 May 2025 Evaluate

Sigachi Industries’ subsidiary -- Trimax Biosciences (Trimax) has achieved the certificate of suitability (CEP) for ‘Metformin Hydrochloride’ from European Directorate for the quality of medicines & health care (EDQM). 

This certification will pave the way for Trimax to export this crucial active pharmaceutical ingredient (API) to Europe and other CEP-accepting markets, further strengthening the company’s presence in highly regulated pharmaceutical markets.

Sigachi Industries is an industry leader in the field of Pharma Excipients, Nutra and food ingredients. The company has rapidly established itself as one of the largest manufacturers of Microcrystalline Cellulose worldwide.

Sigachi Industries Share Price

22.02 -0.46 (-2.05%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×